Definitive Healthcare Corp (DH)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ
Market Cap: $140.38M
Last updated: Nov 17, 2026 at 4:26 PM ET
Definitive Healthcare Corp (DH) Stock Chart
Definitive Healthcare (DH) has a latest price of $1.31 on Nov 17, 2026, 56.3% below its 52-week high of $3.00. Its price fell 52.2% over the past 12 months. The month-end price fell 97.2% over the 5 years through Oct 2026, a compound annual decline of 51.1%.
Price Chart
From Sep 2021 to Oct 2026, its highest month-end close was $42.83 in Sep 2021 and its lowest $0.68 in Jul 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart DH with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for DH.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 82.5%, and over 6 months it rose 50.4%. The month-end price fell 80.6% over the 3 years through Oct 2026, a compound annual decline of 42.1%.
| Period | Change |
|---|---|
| 1 month | +19.1% |
| 3 months | +82.5% |
| 6 months | +50.4% |
| 12 months | -52.2% |
| 12 months, with dividends | -52.2% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -80.6% | -42.1% |
| 5 years | -97.2% | -51.1% |
Price by Year
Its best calendar year was 2023, when the price fell 9.6%, and its weakest was 2022, when it fell 59.8%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $1.12 | -61.0% |
| 2025 | $2.87 | -30.2% |
| 2024 | $4.11 | -58.7% |
| 2023 | $9.94 | -9.6% |
| 2022 | $10.99 | -59.8% |
Trading Range
The price is 23.9% above its 50-day average of $1.06 and 30.0% above its 200-day average of $1.01.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $1.31 | |
| 52-week high | $3.00 | -56.3% |
| 52-week low | $0.61 | +114.8% |
| 50-day average | $1.06 | +23.9% |
| 200-day average | $1.01 | +30.0% |
Price Risk
Over 3 years, its largest fall from a peak was 93.9%.
| Measure | Value |
|---|---|
| 1-year beta | 1.25 |
| Largest fall, 1 year | -78.1% |
| Largest fall, 3 years | -93.9% |
Valuation
Definitive Healthcare traded at 14.3x earnings at the end of 2025, against a 5-year median of 16.6x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About DH
What is DH's 1-year price change?
Definitive Healthcare's price fell 52.2% over the past 12 months. With dividends included, the 12-month total return was -52.2%.
What is DH's 5-year price change?
Definitive Healthcare's month-end price fell 97.2% over the 5 years through Oct 2026, a compound annual decline of 51.1%. These figures leave out dividends.
What is DH's 52-week high and low?
Definitive Healthcare's 52-week high is $3.00 and its 52-week low is $0.61. Its latest price of $1.31 on Nov 17, 2026 is 56.3% below the high.
What is DH's beta?
Definitive Healthcare's 1-year beta against the S&P 500 is 1.25, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 78.1%.
Is the DH chart free?
Yes. Advanced Charting for DH is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
DH pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts